Author Question: In Late Retirement Incentive Programs (LRIPS): a. the employee either accepts the offer or is ... (Read 144 times)

laurencescou

  • Hero Member
  • *****
  • Posts: 593
In Late Retirement Incentive Programs (LRIPS):
 
  a. the employee either accepts the offer or is laid off.
  b. it offers a comprehensive package of insurance coverage as well as pension payments.
  c. workers are encouraged to stay in the workforce
  d. the pension benefits can be passed on to a spouse and children.

Question 2

A primary reason for early retirement inducements offered by corporations is
 
  a. older workers are less reliable because of health problems.
  b. to make room for the ever increasing supply of younger workers.
  c. companies have to pay more money in insurance benefits for older than younger workers.
  d. to downsize operations in order to cut costs and reduce the number of employees aged 50 and over.



Ptupou85

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

ANSWER: c

Answer to Question 2

ANSWER: d



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Sperm cells are so tiny that 400 to 500 million (400,000,000–500,000,000) of them fit onto 1 tsp.

Did you know?

An identified risk factor for osteoporosis is the intake of excessive amounts of vitamin A. Dietary intake of approximately double the recommended daily amount of vitamin A, by women, has been shown to reduce bone mineral density and increase the chances for hip fractures compared with women who consumed the recommended daily amount (or less) of vitamin A.

Did you know?

Drug-induced pharmacodynamic effects manifested in older adults include drug-induced renal toxicity, which can be a major factor when these adults are experiencing other kidney problems.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

In 2006, a generic antinausea drug named ondansetron was approved. It is used to stop nausea and vomiting associated with surgery, chemotherapy, and radiation therapy.

For a complete list of videos, visit our video library